Lumana Invest

Lumana Invest is a Netherlands-based venture capital firm with a specialized focus on the medical technology and biotech sectors. The firm actively invests in seed-stage, early-stage, and later-stage companies, demonstrating a commitment to supporting innovative deep tech solutions. Notable investments include companies such as Neuroplast, Atro Medical, Sencure, Vivolta, and ScoutinScience. In 2025, Lumana Invest's portfolio was integrated into the 819 Evergreen Fund, signaling a strategy centered on long-term, patient capital and sustained partnerships for value creation within critical societal domains. They primarily operate as lead investors in funding rounds.